Although our findings suggest that soluble MHC class II dimer can be used clinically to treat autoimmune disease, human MS is much more complicated than the MOG-induced EAE mouse model, where there is only a single self-peptide involved and the MHC allele is known. The gene discussed is HLA-C; the disease is myeloid sarcoma.